Annexes to COM(2009)268 - Amendment of Regulation (EC) No 998/2003 on the animal health requirements applicable to the non-commercial movement of pet animals

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2009)268 - Amendment of Regulation (EC) No 998/2003 on the animal health requirements applicable to the non-commercial movement of pet ...
document COM(2009)268 EN
date May 19, 2010
ANNEX

‘

ANNEX Ia

Technical requirements for the identification

For the purposes of Article 4(1), the standard electronic identification system shall be a read-only passive radio frequency identification device (“transponder”):

1.complying with ISO Standard 11784 and applying HDX or FDX-B technology;

2.capable of being read by a reading device compatible with ISO Standard 11785.

ANNEX Ib

Technical requirements for the anti-rabies vaccination (Referred to in Article 5(1)(b)(i))

For the purposes of Article 5(1), an anti-rabies vaccination shall be considered valid provided that the following requirements are complied with:

1.The anti-rabies vaccine must:

(a)be a vaccine other than a live modified vaccine and fall within one of the following categories:

(i)an inactivated vaccine of at least one antigenic unit per dose (WHO standard); or

(ii)a recombinant vaccine expressing the immunising glycoprotein of the rabies virus in a live virus vector;

(b)if administered in a Member State, have been granted a marketing authorisation in accordance with:

(i)Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (1); or

(ii)Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (2);

(c)if administered in a third country, meet at least the requirements laid down in Part C of Chapter 2.1.13 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 2008 Edition, of the World Organisation for Animal Health.

2.An anti-rabies vaccination may only be considered valid if it meets the following conditions:

(a)the vaccine was administered on a date indicated in:

(i)Section IV of the passport; or

(ii)the appropriate section of the accompanying animal health certificate;

(b)the date referred to in point (a) must not precede the date of microchipping indicated in:

(i)Section III(2) of the passport; or

(ii)the appropriate section of the accompanying animal health certificate;

(c)at least 21 days must have elapsed since the completion of the vaccination protocol required by the manufacturer for the primary vaccination in accordance with the technical specification of the marketing authorisation referred to in point 1(b) for the anti-rabies vaccine in the Member State or third country in which the vaccination is administered;

(d)the period of validity of the vaccination, as prescribed in the technical specification of the marketing authorisation for the anti-rabies vaccine in the Member State or third country where the vaccine is administered, must have been entered by the authorised veterinarian in:

(i)Section IV of the passport; or

(ii)the appropriate section of the accompanying animal health certificate;

(e)a revaccination (booster) must be considered a primary vaccination if it was not carried out within the period of validity referred to in point (d) of a previous vaccination.

’

(1) OJ L 311, 28.11.2001, p. 1.

(2) OJ L 136, 30.4.2004, p. 1.


Statement of the European Parliament, the Council and the Commission on Article 290 TFEU

The European Parliament, Council and Commission declare that the provisions of this Regulation shall be without prejudice to any future position of the institutions as regards the implementation of Article 290 TFEU or individual legislative acts containing such provisions.


Statement by the Commission

The Commission has the intention to propose a revision of Regulation (EC) No 998/2003 in its entirety before 30 June 2011, and, in particular, the aspects of delegated and implementing acts.


Statement by the Commission concerning the notification of delegated acts

The European Commission takes note that except in cases where the legislative act provides for an urgency procedure, the European Parliament and the Council consider that the notification of delegated acts, shall take into account the periods of recess of the institutions (winter, summer and European elections), in order to ensure that the European Parliament and the Council are able to exercise their prerogatives within the time limits laid down in the relevant legislative acts, and is ready to act accordingly.